Oct. 12 (Thu.) ,2017 15:00-16:30

Annex Hall

Simultaneous Interpretation

【O-9】 R&D of RM products in Japan

Latest R&D of Regenerative Medicine and Gene Therapy products in Japan will be presented by the representatives of each companies.


Akihiko Iwai

Vice-chairman, Divisional Senior Vice President, Forum for Innovative Regenerative Medicine / Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma

Takeda-CiRA joint program(T-CiRA): An industy-academia collabolation in an attempt to overcome the "Valley of death"

Seigo Izumo

Global Head of Regenerative Medicine Unit, Head of Scientific Affairs, Japan, Takeda Pharmaceutial Company Limited

Issues and solutions for the implementation of regenerative medicines

Kunio Yamada

Chairman & Chief Executive Officer, ROHTO PHARMACEUTICAL

Latest development of gene therapy using AAV vector

Katsuhito Asai

President & CEO, Gene Therapy Research Institution

Close Window